Monday, October 12, 2009

Dendreon Expands Board

Seattle-based Dendreon announced today that it has added Ian Clark and Pedro Granadillo to the firm's board of directors. Clark is Head of Global Product Strategy and Chief Marketing Officer at Roche, Pharma Division, and is becoming CEO of Genentech; Granadillo is retired, but previously served as SVP of Global Manufacturing and Human Resources at Eli Lilly & Company. Granadillo is also on the boards of Haemonetics Corporation, Nile Therapeutics and Tigris Pharmaceuticals.